HBM Healthcare Investments (Cayman) Ltd. - 31 Mar 2025 SCHEDULE 13G/A Report for ALX ONCOLOGY HOLDINGS INC Common Stock, par value $0.001 per share (ALXO)

Filing Manager
HBM Healthcare Investments (Cayman) Ltd.
Reporting Manager
HBM Healthcare Investments (Cayman) Ltd.
Security
ALX ONCOLOGY HOLDINGS INC Common Stock, par value $0.001 per share
Symbol
ALXO
Shares outstanding
53,571,429 shares
Disclosed Ownership
4,500,000 shares
Ownership
8.4%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 16:05:22 UTC
Date of event
31 Mar 2025
Previous filing
27 Dec 2024
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"HBM Healthcare Investments (Cayman) Ltd. disclosed 8.4% ownership in ALX ONCOLOGY HOLDINGS INC Common Stock, par value $0.001 per share (ALXO) on 31 Mar 2025."

Quick Takeaways

  • HBM Healthcare Investments (Cayman) Ltd. filed SCHEDULE 13G/A for ALX ONCOLOGY HOLDINGS INC Common Stock, par value $0.001 per share (ALXO).
  • Disclosed ownership: 8.4%.
  • Date of event: 31 Mar 2025.

What Changed

  • Previous schedule filing date: 27 Dec 2024.
  • Current filing was accepted on 15 May 2025, 16:05.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
HBM Healthcare Investments (Cayman) Ltd. 8.4% 4,500,000 4,500,000 0 /s/ Jean-Marc LeSieur Jean-Marc LeSieur, Managing Director

Sponsored